CHEK1 and glioblastoma: As we obtained significant DNA damage-response signaling in GBM cells with NSC745887 treatment, we also examined expressions of cell cycle-associated proteins, such as the phosphatase activity of cell division cyclin 25 (CDC25) which is inactivated by CHK1/CHK2 [31].